These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34608924)

  • 41. Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.
    Marengo E; Robotti E
    World J Gastroenterol; 2014 Oct; 20(37):13325-42. PubMed ID: 25309068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches.
    Lee D; Park Y; Kim S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 34020548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
    Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
    Hernández-Vargas P; Muñoz M; Domínguez F
    Hum Reprod Update; 2020 Feb; 26(2):264-301. PubMed ID: 32096829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current omics-based biomarkers for cholangiocarcinoma.
    Intuyod K; Armartmuntree N; Jusakul A; Sakonsinsiri C; Thanan R; Pinlaor S
    Expert Rev Mol Diagn; 2019 Nov; 19(11):997-1005. PubMed ID: 31566016
    [No Abstract]   [Full Text] [Related]  

  • 47. Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers.
    Sehgal V; Seviour EG; Moss TJ; Mills GB; Azencott R; Ram PT
    PLoS One; 2015; 10(10):e0140072. PubMed ID: 26505200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A survey on single and multi omics data mining methods in cancer data classification.
    Momeni Z; Hassanzadeh E; Saniee Abadeh M; Bellazzi R
    J Biomed Inform; 2020 Jul; 107():103466. PubMed ID: 32525020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data.
    Zhao N; Guo M; Wang K; Zhang C; Liu X
    Front Bioeng Biotechnol; 2020; 8():268. PubMed ID: 32300588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
    Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
    Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification.
    Wu D; Wang D; Zhang MQ; Gu J
    BMC Genomics; 2015 Dec; 16():1022. PubMed ID: 26626453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
    Dimitrakopoulos L; Prassas I; Diamandis EP; Charames GS
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):414-432. PubMed ID: 29025326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent trends of saliva omics biomarkers for the diagnosis and treatment of oral cancer.
    Chattopadhyay I; Panda M
    J Oral Biosci; 2019 Jun; 61(2):84-94. PubMed ID: 31109866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
    Li R; Wang S; Cui Y; Qu H; Chater JM; Zhang L; Wei J; Wang M; Xu Y; Yu L; Lu J; Feng Y; Zhou R; Huang Y; Ma R; Zhu J; Zhong W; Jia Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32898860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis.
    Ouyang X; Fan Q; Ling G; Shi Y; Hu F
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Convolutional neural network for human cancer types prediction by integrating protein interaction networks and omics data.
    Chuang YH; Huang SH; Hung TM; Lin XY; Lee JY; Lai WS; Yang JM
    Sci Rep; 2021 Oct; 11(1):20691. PubMed ID: 34667236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survey and comparative assessments of computational multi-omics integrative methods with multiple regulatory networks identifying distinct tumor compositions across pan-cancer data sets.
    Wei Z; Zhang Y; Weng W; Chen J; Cai H
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32533167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A survey on computational approaches to identifying disease biomarkers based on molecular networks.
    Qin G; Zhao XM
    J Theor Biol; 2014 Dec; 362():9-16. PubMed ID: 24931674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.